DOTE Évkönyv 1993-94

the biochemistry of programmed cell death. In: Retinoids and Development,Morris-Kay, G., ed., Oxford University Press, 249-263.12. Fésüs, L., Davies, P.J.A. and Piacentini, M.: Molecular mechanisms in theprogram of cell death by apoptosis (review). European Journal of Cell Biology56, 170-177. 1991.13. Fésüs, L., Nagy, L., Basilion, J. and Davies, P.J.A. Retinoic acid transcripts inhuman umbilical vein endothelial cells. Biochemical Biophysical ResearchCommunications 179, 32–38. 1991.14. Reichert, U. and Fésüs, L.: Programmed cell death (review). Retinoids Todayand Tomorrow 24, 31–34. 1991.15. Piacentini, M., Ceru, M.P., Dini, L., Di Rao, M., Piredda, l., Thomazy, V.,Davies, P.J.A. and Fésüs, L.: In vivo and in vitro induction of "tissue"transglutaminase in rat hepatocytes by retinoic acid. Biochimica andBiophysica Acta 1135, 171–179. 1992.16. Mehta, K., Rao, U.R., Vickery, A.C. and Fésüs, L.: Identification of a noveltransglutaminase from the filarial parasite Brugia malayi and its role in growthand development. Molecular and Biochemical Parasitology 53, 11–16. 1992.17. Szabó, G., Schablik, M., Kiss, Á., Koncz, Cs., Bognár, R., Pelyvás, I., andSztaricskai, F.: A new cyclitol derivative influences inositol metabolism inNeurospora crassa FEMS. Microbiology Letters 82, 15–18. 1991.18. Punyiczki, M., and Rosenberg, A.: The effect of viscosity on the acessibilityof the single tryptophan in HSA. Biophysical Chemistry 42, 93–101. 1992.19. Punyiczki, M., Tőzsér, J. and Berta, A.: Determination of collagenolyticactivity in human tears by microtiter method. Clinical Chemical EnzymologyCommunications 4, 429–237. 1992.20. Somogyi, B.,Norman, A.J., Punyiczki, M., Rosenberg, A.: Viscositydependence of acrylamide quenching of RNase T1 fluorescence. The gatingmechanism. Biochimica Biophysica Acta 1119, 81–89. 1992.21. Szondy, Z., and Newsholme, E.A.: The effects of time of addition ofglutamine or nucleosides on proliferation of rat cervical lymph node T-lymphocytes after stimulation by concanavalin. A Biochemical Journal 278,471–474. 1991.22. Hársfalvi, J., Tarcsa, E., Udvardy, M., Zajka, G., Szarvas, T. and Fésüs, L.:Presence and possible origine of _(_-glutamyl)lysine isodipeptide in humanplasma Thrombosis and Haemostasis 67, 60–62. 1992.23. Piacentini, M., Thomázy, V., Tarcsa, E., Farrace, M.G., Autuori, F. andFésüs, L.: Role of transglutaminase in the formation of apoptotic bodies. In:Modulating Factors in Multistage Carcinogenesis, Columbano, A. and Pani,P., eds., Plenum Press, New York, 461–472. 1991.24. Tőzsér, J., Gustchina, A., Weber, I.T., Bláha,I., Wondrak, E.M., andOroszlan, S.: Studies on the role of the S4 substrate binding site of HIVproteinases. FEBS Letters 279, 356–369. 1991.25. Tőzsér, J., Bláha,I., Copeland, T.D., Wondrak, E.M., and Oroszlan, S.:Comparison of the HIV-1 and HIV-2 proteinases using oligopeptide substratesrepresenting cleavage sites in Gag and Pag-Pol polyproteins. FEBS Letters281, 77-80. 1991.26. Berta, A., and Tőzsér, J. : Plasminogen activator and plasminogen activatorinhibitor determinations in the tears of patients with keratoconjunctivitis siccaan Sjörgen's syndrome. In: New frontiers in ophthalmology, Khoo, C.Y. et al.,eds., Elsevier Science Publishers, B.V., Amsterdam, 777–779. 1991.39